Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

979
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
979
Non-equilibrium in the Cell01:16

Non-equilibrium in the Cell

4.7K
An important concept in studying metabolism and energy is that of chemical equilibrium. Most chemical reactions are reversible. They can proceed in both directions, releasing energy into their environment in one direction, and absorbing it from the environment in the other direction. The same is true for the chemical reactions involved in cell metabolism, such as the breaking down and building up of proteins into and from individual amino acids, respectively. Reactants within a closed system...
4.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy, Structure-Activity Relationship, and Mode of Action Studies of a New Generation of Acridine/Acridone-Based Antimalarials.

ACS infectious diseases·2026
Same author

MegaTrans-machine learning models for drug transporters corresponding to the FDA guidance.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same author

Repurposing Clinical Candidates for Nipah and Hendra Viruses.

ACS infectious diseases·2026
Same author

Enhanced Antiviral Activity of Novel Umifenovir Derivatives against SARS-CoV-2: Insights from an International Collaborative Study.

ACS omega·2026
Same author

Palmitoyl-protein thioesterase-1 in health and disease.

Trends in pharmacological sciences·2026
Same author

Enzyme replacement therapy for CLN1 batten disease that crosses the blood-brain-barrier.

Molecular genetics and metabolism·2026

Related Experiment Video

Updated: Aug 26, 2025

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.7K

The Commoditization of AI for Molecule Design.

Fabio Urbina1, Sean Ekins1

  • 1Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, NC 27606, USA.

Artificial Intelligence in the Life Sciences
|October 10, 2022
PubMed
Summary

Artificial intelligence (AI) and machine learning (ML) are revolutionizing molecule design in life sciences, accelerating discovery and optimization. These computational tools are becoming essential for efficient "AI-designed" molecules, integrating into automated workflows.

Keywords:
Artificial intelligencedesign-make-testmachine learningmolecule designrecurrent neural networks

More Related Videos

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

7.8K
A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

12.7K

Related Experiment Videos

Last Updated: Aug 26, 2025

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.7K
Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

7.8K
A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

12.7K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Materials science

Background:

  • The COVID-19 pandemic accelerated the adoption of computational technologies in molecule design.
  • Artificial intelligence (AI) and machine learning (ML) have become integral tools for scientists working remotely.
  • AI and ML are transforming the pharmaceutical industry, becoming a commodity for molecule design and optimization.

Purpose of the Study:

  • To provide an opinion on the evolution and application of ML in modeling molecular properties across industries.
  • To explore the integration of AI into automated experimental pipelines and equipment.
  • To highlight the impact of AI and ML on molecule design and the drug discovery process.

Main Methods:

  • Review of current AI and ML applications in molecule design.
  • Discussion of generative models and their architectures for *de novo* molecule design.
  • Analysis of industry trends and companies leading AI adoption in molecule design.

Main Results:

  • AI and ML are increasingly used for designing and optimizing molecules.
  • Generative models are being implemented for *de novo* molecular design.
  • AI is influencing and impacting molecule design workflows across various industries.

Conclusions:

  • AI and ML are poised to significantly increase the efficiency of the design-make-test cycle.
  • The future of molecule design will involve tighter integration of AI into automated experimental pipelines.
  • Continued advancements in AI technologies will shape the future of molecular discovery and development.